For the treatment of severe COPD in recent decades, the long-term oxygen was really only available in isolated cases, sometimes even a lung transplant.

In recent years countries have joined the non-invasive ventilation with a removable facemask for use at home as a very big step forward. Their positive treatment effects are described in other countries, however, as only slight. In some countries, the insurance companies do even not accept a ventilator! Background of this is an incorrect selection of patients that would be suitable for scientific studies, and secondly, the different manner in which ventilation is performed in those countries – which differs from the practice of this country that is very different.

Examining selective COPD patients with an enrichment of carbon dioxide in the blood (hypercapnia), the success of non-invasive ventilation is undoubtedly very clear. However, it needs a lot of experience to adjust the patient’s right to mask ventilation.

All COPD patients with an enrichment of carbon dioxide in the blood (hypercapnia) have chronically congested respiratory muscles, because they constantly have to breathe against increased resistance due to their chronic airway obstruction (obstruction). If these patients (mostly at night) by a respirator mask so that young people’s breathing is almost suppressed the respiratory muscles can recover and regain your energy (glycogen). Thanks to the recovery of energy can then make the respiratory muscles by breathing significantly more, which is shown, for example, in a doubling of physical exercise capacity of patients. As this therapy is quite simple: The patient must learn to fully suspend its work of respiratory muscles during respiration. There are now afford such devices, which help. In addition, there is a wide variety of different types of masks that can be individually optimized so that in almost all cases, the ventilator and then carried out without discomfort.

In our experience, well worth taking a breathing treatment when the pCO2 value) (carbon dioxide partial lies well above 50 mm Hg. Then 80 to 90% of patients benefit from a non-invasive ventilation.